These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 25240975)
1. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model. van der Zwan YG; Biermann K; Wolffenbuttel KP; Cools M; Looijenga LH Eur Urol; 2015 Apr; 67(4):692-701. PubMed ID: 25240975 [TBL] [Abstract][Full Text] [Related]
2. Role of epigenetics in the etiology of germ cell cancer. Van Der Zwan YG; Stoop H; Rossello F; White SJ; Looijenga LH Int J Dev Biol; 2013; 57(2-4):299-308. PubMed ID: 23784841 [TBL] [Abstract][Full Text] [Related]
3. Tumor risk in disorders of sex development (DSD). Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493 [TBL] [Abstract][Full Text] [Related]
4. New insight into the aetiology of testicular germ cell tumours. Huddart R Eur Urol; 2015 Apr; 67(4):702-3. PubMed ID: 25497430 [No Abstract] [Full Text] [Related]
5. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD). Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106 [TBL] [Abstract][Full Text] [Related]
6. The biology of germ cell tumors in disorders of sex development. Hersmus R; van Bever Y; Wolffenbuttel KP; Biermann K; Cools M; Looijenga LH Clin Genet; 2017 Feb; 91(2):292-301. PubMed ID: 27716895 [TBL] [Abstract][Full Text] [Related]
7. Tumor risk and clinical follow-up in patients with disorders of sex development. Cools M; Looijenga LH Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():519-24. PubMed ID: 22423509 [TBL] [Abstract][Full Text] [Related]
8. Gonadal tumours and DSD. Looijenga LH; Hersmus R; de Leeuw BH; Stoop H; Cools M; Oosterhuis JW; Drop SL; Wolffenbuttel KP Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):291-310. PubMed ID: 20541153 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development. Jørgensen A; Lindhardt Johansen M; Juul A; Skakkebaek NE; Main KM; Rajpert-De Meyts E Semin Cell Dev Biol; 2015 Sep; 45():124-37. PubMed ID: 26410164 [TBL] [Abstract][Full Text] [Related]
10. Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology. Looijenga LHJ; Kao CS; Idrees MT Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658757 [TBL] [Abstract][Full Text] [Related]
11. Development of malignant germ cells - the genvironmental hypothesis. Looijenga LH; Van Agthoven T; Biermann K Int J Dev Biol; 2013; 57(2-4):241-53. PubMed ID: 23784835 [TBL] [Abstract][Full Text] [Related]
12. Tumor risk in disorders of sex development. Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977 [TBL] [Abstract][Full Text] [Related]
13. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Ulbright TM Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467 [TBL] [Abstract][Full Text] [Related]
14. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients. Slowikowska-Hilczer J; Szarras-Czapnik M; Wolski JK; Oszukowska E; Hilczer M; Jakubowski L; Walczak-Jedrzejowska R; Marchlewska K; Filipiak E; Kaluzewski B; Baka-Ostrowska M; Niedzielski J; Kula K Folia Histochem Cytobiol; 2015; 53(3):218-26. PubMed ID: 26314751 [TBL] [Abstract][Full Text] [Related]
15. Is a CIS phenotype apparent in children with Disorders of Sex Development? Milder testicular dysgenesis is associated with a higher risk of malignancy. Chemes HE; Venara M; Del Rey G; Arcari AJ; Musse MP; Papazian R; Forclaz V; Gottlieb S Andrology; 2015 Jan; 3(1):59-69. PubMed ID: 25598272 [TBL] [Abstract][Full Text] [Related]
16. Gonadal malignancy in 13 consecutive collected patients with disorders of sex development (DSD) from Semarang (Indonesia). Juniarto AZ; Setyawati BA; Miranti IP; Santosa A; Hersmus R; Stoop H; Cools M; Oosterhuis JW; Drop SL; Faradz SM; Looijenga LH J Clin Pathol; 2013 Mar; 66(3):198-204. PubMed ID: 23268320 [TBL] [Abstract][Full Text] [Related]
17. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). Hersmus R; Kalfa N; de Leeuw B; Stoop H; Oosterhuis JW; de Krijger R; Wolffenbuttel KP; Drop SL; Veitia RA; Fellous M; Jaubert F; Looijenga LH J Pathol; 2008 May; 215(1):31-8. PubMed ID: 18348162 [TBL] [Abstract][Full Text] [Related]
18. Advances in molecular markers of germ cell cancer in patients with disorders of sex development. van der Zwan YG; Cools M; Looijenga LH Endocr Dev; 2014; 27():172-84. PubMed ID: 25247654 [TBL] [Abstract][Full Text] [Related]
19. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Cools M; Drop SL; Wolffenbuttel KP; Oosterhuis JW; Looijenga LH Endocr Rev; 2006 Aug; 27(5):468-84. PubMed ID: 16735607 [TBL] [Abstract][Full Text] [Related]
20. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis. Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]